Mersana Therapeutics
MRSN
$3.46
Share price
3.12%
Change (1 day)
-20.89%
Change (1 year)
Categories
Mersana Therapeutics (MRSN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.18 B
According to Mersana Therapeutics's latest financial reports the company's total liabilities are $0.18 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Mersana Therapeutics - Total liabilities on balance sheet (from 2016 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.18 B | -21.93% |
| 2022-12-31 | $0.24 B | 187.17% |
| 2021-12-31 | $84.37 M | 86.2% |
| 2020-12-31 | $45.31 M | 55.06% |
| 2019-12-31 | $29.22 M | -58.08% |
| 2018-12-31 | $69.7 M | 14.8% |
| 2017-12-31 | $60.72 M | -62.22% |
| 2016-12-31 | $0.16 B | 181.44% |
| 2015-12-31 | $57.1 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -85.24% | 🇺🇸 USA |